Aybintio (abaloparatide)
Aybintio is a prescription medicine used to treat osteoporosis in postmenopausal women at high risk…
Evaluation of a Novel TB Drug SQ109 to Shorten and Simplify the treatment of Experimental Tuberculosis (TB) SQ109 (ethambutol analogue) is a novel drug undergoing development for treatment of drug-resistant tuberculosis. 1.1.1 Pharmacokinetic properties of SQ109 Pharmacokinetic characteristics of SQ109, received on preclinical trial show evidence of relatively high efficiency even on the onset of…… Read More »
Tuberculosis (phthísis) is a highly contagious infectious disease caused by mycobacterium tuberculosis, which is acquired by inhaling a contaminated airborne droplet. In 95% of cases, TB occurs via constant exposure within a period of two months…. Read More »